Ampio Pharmaceuticals, Inc. (AMPE)

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011 - 2007
Cash & Equivalents	33.89	17.35	6.53	7.59	8.24	4.93	16.03	50.36	26.35	17.7	Upgrade
Short-Term Investments	0	0	0	0	0	0.12	0	0	0	0	Upgrade
Cash & Cash Equivalents	33.89	17.35	6.53	7.59	8.24	5.05	16.03	50.36	26.35	17.7	Upgrade
Cash Growth	95.39%	165.55%	-13.88%	-7.98%	63.18%	-68.49%	-68.16%	91.08%	48.87%	-	Upgrade
Receivables	0	0	0	0	0	0	0.04	0	0	0	Upgrade
Other Current Assets	1.74	1.15	1.72	0.45	0.2	0.35	13.16	0.9	0.09	0.14	Upgrade
Total Current Assets	35.63	18.49	8.25	8.03	8.44	5.4	29.23	51.26	26.44	17.85	Upgrade
Property, Plant & Equipment	3.19	4.39	5.75	6	6.84	7.98	9.19	9.95	1.3	0.06	Upgrade
Goodwill and Intangibles	0	0	0	0	0	0	0	0.66	0.73	0.42	Upgrade
Other Long-Term Assets	0	0	0	0	0.03	0.21	12	8.4	7.54	7.52	Upgrade
Total Long-Term Assets	3.19	4.39	5.75	6	6.87	8.19	21.19	19.01	9.58	8	Upgrade
Total Assets	38.83	22.88	14	14.03	15.31	13.6	50.42	70.27	36.02	25.85	Upgrade
Accounts Payable	4.81	1.55	4.03	1.32	2.79	0.71	1.8	3.3	1.9	1.2	Upgrade
Deferred Revenue	0	0	0	0	0	0	0	0.55	0.38	0.43	Upgrade
Other Current Liabilities	0.31	0.28	0.26	0.06	1.09	1.43	3.71	-0.17	0.19	0	Upgrade
Total Current Liabilities	5.12	1.83	4.28	1.38	3.88	2.13	5.52	3.68	2.47	1.64	Upgrade
Long-Term Debt	0.61	0.93	1.21	0.48	0	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	5.81	2.61	2.06	6.93	45.61	4.83	6.98	1.13	0.33	0.38	Upgrade
Total Long-Term Liabilities	6.42	3.53	3.27	7.41	45.61	4.83	6.98	1.13	0.33	0.38	Upgrade
Total Liabilities	11.54	5.37	7.56	8.79	49.49	6.96	12.49	4.81	2.8	2.02	Upgrade
Total Debt	0.61	0.93	1.21	0.48	0	0	0	0	0	0	Upgrade
Debt Growth	-33.62%	-23.55%	153.67%	-	-	-	-	-	-	-	Upgrade
Common Stock	244.89	218.04	191.08	176.24	170.81	159.71	170.91	168.02	96.86	63.6	Upgrade
Retained Earnings	-217.6	-200.53	-184.63	-171	-204.99	-153.08	-133.91	-101.9	-63.78	-39.77	Upgrade
Shareholders' Equity	27.28	17.51	6.44	5.24	-34.18	6.63	37	66.12	33.08	23.83	Upgrade
Total Liabilities and Equity	38.83	22.88	14	14.03	15.31	13.6	49.49	70.93	35.88	25.85	Upgrade
Net Cash / Debt	33.28	16.42	5.32	7.11	8.24	5.05	16.03	50.36	26.35	17.7	Upgrade
Net Cash / Debt Growth	102.66%	208.55%	-25.13%	-13.77%	63.18%	-68.49%	-68.16%	91.08%	48.87%	-	Upgrade
Net Cash Per Share	0.17	0.10	0.04	0.10	0.13	0.09	0.31	1.00	0.69	0.52	Upgrade
Working Capital	30.51	16.66	3.97	6.65	4.56	3.27	23.71	47.58	23.97	16.21	Upgrade
Book Value Per Share	0.14	0.10	0.05	0.07	-0.52	0.12	0.71	1.32	0.86	0.70	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).